TK2d

News

People living with thymidine kinase 2 deficiency (TK2d), a vanishingly rare and often fatal genetic disorder, finally have an approved therapy.

News

UCB's experimental medicine for TK2d, currently under regulatory review, offers hope to patients with the devastating rare disease.

News

The UK government has responded to calls to broaden vaccinations for meningitis B, offering the jab to "thousands" of young people this summer.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.